The estimated Net Worth of Todd Newton is at least $3.82 Million dollars as of 10 May 2019. Mr. Newton owns over 25,000 units of Apollo Endosurgery Inc stock worth over $3,176,680 and over the last 8 years he sold APEN stock worth over $0. In addition, he makes $647,096 as Chief Executive Officer and Director at Apollo Endosurgery Inc.
Sign up
Mr. Newton APEN stock SEC Form 4 insiders trading
Todd has made over 4 trades of the Apollo Endosurgery Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 25,000 units of APEN stock worth $88,250 on 10 May 2019.
The largest trade he's ever made was buying 136,363 units of Apollo Endosurgery Inc stock on 25 July 2017 worth over $749,997. On average, Todd trades about 12,432 units every 38 days since 2016. As of 10 May 2019 he still owns at least 317,668 units of Apollo Endosurgery Inc stock.
You can see the complete history of Mr. Newton stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Todd Newton biography
Todd Newton CPA serves as Chief Executive Officer, Director of the Company. Since July 2014, Mr. Newton has served as Chief Executive Officer and as a member of our Board. From April 2009 to June 2014, Mr. Newton served as Executive Vice President, Chief Financial Officer and Chief Operating Officer at ArthroCare Corporation, a medical device company. Since June 2019, Mr. Newton has served on the Board of Directors of Mimedx Group, Inc., a publicly traded advanced wound care and therapeutic biologics company. Mr. Newton holds a B.B.A. in Accounting from The University of Texas at San Antonio.
What is the salary of Todd Newton?
As the Chief Executive Officer and Director of Apollo Endosurgery Inc, the total compensation of Todd Newton at Apollo Endosurgery Inc is $647,096. There are 1 executives at Apollo Endosurgery Inc getting paid more, with Christopher Gostout having the highest compensation of $1,156,870.
How old is Todd Newton?
Todd Newton is 57, he's been the Chief Executive Officer and Director of Apollo Endosurgery Inc since 2014. There are 9 older and 7 younger executives at Apollo Endosurgery Inc. The oldest executive at Apollo Endosurgery Inc is Dr. Christopher J. Gostout, 70, who is the Co-Founder & Chief Medical Officer.
What's Todd Newton's mailing address?
Todd's mailing address filed with the SEC is 1120 S Capital of Texas Hwy #300, Austin, TX 78746, USA.
Insiders trading at Apollo Endosurgery Inc
Over the last 12 years, insiders at Apollo Endosurgery Inc have traded over $3,882,241 worth of Apollo Endosurgery Inc stock and bought 10,717,094 units worth $45,588,363 . The most active insiders traders include Holdings A/S Novo, Neil Gagnon, and R Kent Jr Mc Gaughy. On average, Apollo Endosurgery Inc executives and independent directors trade stock every 41 days with the average trade being worth of $2,726,880. The most recent stock trade was executed by Jeffrey G. Black on 25 February 2022, trading 40,000 units of APEN stock currently worth $229,200.
What does Apollo Endosurgery Inc do?
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
What does Apollo Endosurgery Inc's logo look like?
Complete history of Mr. Newton stock trades at Apollo Endosurgery Inc and MiMedx Inc
Apollo Endosurgery Inc executives and stock owners
Apollo Endosurgery Inc executives and other stock owners filed with the SEC include:
-
Christopher Gostout,
Chief Medical Officer -
Todd Newton,
Chief Executive Officer, Director -
John J. Molesphini,
Exec. VP of Operations -
Bret Schwartzhoff,
Vice President - North America Sales and Global Marketing -
Stefanie Cavanaugh,
Chief Financial Officer, Secretary -
K. Todd Newton,
Consultant -
Bret Schwartzhoff,
VP, US Sales & Global Marketing -
Julie Shimer,
Independent Director -
Bruce Robertson,
Independent Director -
David Pacitti,
Independent Director -
R. Kent McGaughy,
Independent Director -
William McClellan,
Independent Director -
John Barr,
Independent Director -
Rick Anderson,
Independent Director -
John Molesphini,
Executive Vice President - Operations -
Dr. Christopher J. Gostout M.D.,
Co-Founder & Chief Medical Officer -
Jeffrey G. Black,
Chief Financial Officer -
Dr. Pankaj Jay Pasricha FACP, M.D., MBBS,
Co-Founder -
Dr. Christopher J. Gostout,
Co-Founder & Chief Medical Officer -
Sydney Chung M.D.,
Co-Founder and Innovation Partner -
Dr. Peter Benjamin Cotton M.D.,
Co-Founder and Innovation Partner -
Dr. Robert Hawes M.D.,
Co-Founder and Innovation Partner -
Anthony Kalloo M.D.,
Co-Founder and Innovation Partner -
Dr. Sergey Kantsevoy M.D.,
Co-Founder and Innovation Partner -
Charles S. McKhann,
CEO, Pres & Director -
Sciences Ii L Pptv Iv, L.P....,
-
Ventures Llc Remeditex,
10% owner -
Richard J Meelia,
Director -
Dennis L. Mc Williams,
President, CCO -
Ventures Endosurgery, Llc...,
10% owner -
Holdings A/S Novo,
10% owner -
John W Creecy,
Director -
Charles Tribie,
Executive V.P. of Operations -
Chas Mc Khann,
President and CEO -
Sciences Ii L Pptv Iv, L.P....,
-
Sciences Ii L Pptv Iv, L.P....,
-
Capital, L.P. Stonepine,
10% owner -
Sciences Ii L Pptv Special ...,
-
Inc Cpmg,
-
James W Jr Traweek,
-
Neil Gagnon,
10% owner -
Sciences Ii L Pptv Iv, L.P....,
-
Inc Desai Antal Rohit Cpmg,
-
Matthew S Crawford,
10% owner -
Jeffrey G. Black,
Chief Financial Officer -
Mike Gutteridge,
VP, Int'l Sales and Marketing -
Sharon O'keefe,
Director -
Jeannette Bankes,
Director